Deals
TPG Said Near Deal to Purchase Envision Pharmaceutical
This article is for subscribers only.
TPG Capital, the private-equity firm started by David Bonderman and Jim Coulter, is close to an agreement to buy pharmacy-benefits manager Envision Pharmaceutical Holdings Inc., according to a person with direct knowledge of the transaction. Terms weren’t disclosed.
The deal may be announced as early as today, said the person, who asked not to be identified because the agreement isn’t final. Envision, founded in 2001, has annual revenue of more than $3.5 billion.